Clearside Biomedical (CLSD) Reports In-Line Q4 EPS
Tweet
Share
E-mailClearside Biomedical (NASDAQ: CLSD) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $306 thousand versus the consensus estimate of $130.14 thousand.
For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
